Caranx medical develops the AIIR platform to broaden the adoption of endoluminal techniques worldwide
Increasing demand worldwide drives the market
Today, endoluminal treatments exist to treat certain diseases, like TAVI for the structural heart or the Endo gastric sleeve for bariatrics. However, these techniques remain complex and require a significative learning curve, limiting their adoption at a large scale. In parallel, treatment needs of the world’s population continue to grow significantly.
Population growth is driving increasing demand globally, both in developed and emerging countries
of the growth by 2045
Aging of population increases dramatically number of patients suffering from cardiovascular or metabolic diseases worldwide
people in middle class by 2030
GROWING ACCESS TO HEALTHCARE
The emergence of a middleclass with increased financial means impacts the demand for access to advanced care in many regions
Shortage of specialized clinicians put pressure on healthcare systems
Even in the most developed countries, there is already a shortage of specialized clinicians, such as neuro-radio interventionalists or interventional cardiologists. This pressure on healthcare systems will continue to increase in the coming years, affecting patients’ access to care.
54 000 - 139 000
clinicians by 2033
IN THE US
IN THE EUROPE
cardiologists by 2025 in the US
Across the globe, 6.4M physicians are needed
With AiiR platfrom, we aim at initiating this shift, by simplifying complex procedures and giving greater access to minimally-invasive care to patients worldwide.
AI trained on our own multi-modal database relying on several thousands of patients, allowing to build a digital twin able to anticipate potential complications and to make specific recommendations for a specific patient.
Real-time multi-modal medical image analysis allow fast and intelligent decision-making.
Autonomous motions supervised by the clinician allowing higher precision. The clinician can also teleoperate the robot with AI guidance at any stage.
TAVIPILOT is the first application of the Caranx medical AiiR platform that will enable a more precise aortic valve positioning, leading to reaching the level of experts.
Caranx’s team is very proud of its Innovation award won at I-NOV 2023, organized by BPI France-Ademe.
Caranx is happy to welcome on board new members of Obelia Clinical Advisory board:
Dr Bastid, Gastroenterologist, France
Dr Manos, Gastroenterologist, France
Caranx’s team continues to grow! The company will expand its R&D facilities in Nice, to support the development of TAVIPILOT and OBELIA projects.